
Febinta-M Tablet
Marketer
Doxis Laboratories
Salt Composition
Flupenthixol (0.5mg) + Melitracen (10mg)
Overview Febinta-M Tablet
Deprexa Duo tablets combine two active ingredients to effectively manage depressive symptoms. This medication works by boosting brain neurotransmitters, promoting relaxation and alleviating depression. Deprexa Duo can be administered with or without food, consistently at the same time daily for optimal therapeutic levels. Always follow your physician's prescribed dosage and duration. Abrupt cessation is strongly discouraged; consult your doctor before discontinuing treatment to prevent symptom exacerbation. Potential side effects include xerostomia, constipation, urinary difficulty, visual blurring, tachycardia, muscle stiffness, akathisia, and tremors. Postural hypotension may occur initially; rise slowly from a seated or lying position. Dizziness and somnolence are also possible; avoid driving or activities requiring alertness until effects are known. Prior to commencing treatment, disclose any pre-existing conditions such as thyroid dysfunction, renal impairment, epilepsy, Parkinson's disease, glaucoma, or cardiac disease. Weight gain is a potential consequence; maintain a balanced diet, limit high-calorie snacks, and engage in regular physical activity.
Primary Ingredients of Febinta-M Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Febinta-M Tablet
Managing Depressive Disorders
Major Benefits of Febinta-M Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Febinta-M Tablets can be consumed with or without food, however, consistent daily timing is recommended.
Common Side effects of Febinta-M Tablet:
- Constipation
- Urinary retention
- Weight gain
- Sleepiness
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Increased heart rate
- Increased prolactin level in blood
- Blurred vision
- Dryness in mouth
- Muscle stiffness
- Tremors
- Restlessness
How to use Febinta-M Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Febinta-M Tablets can be consumed with or without food, though consistent timing is recommended.
How Febinta-M Tablet works:
Febinta-M Tablets contain Flupenthixol and Melitracen, two active pharmaceutical ingredients. Flupenthixol, a first-generation antipsychotic, modulates dopamine neurotransmission, a brain process influencing thought and emotional state. Melitracen, a tricyclic antidepressant, elevates levels of key neurotransmitters to improve mood regulation and alleviate depressive symptoms.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Febinta-M Tablets.
PregnancyCONSULT YOUR DOCTOR
Use of Febinta-M Tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the benefits against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on Febinta-M Tablet use while breastfeeding is absent. Seek your physician's advice.
DrivingUNSAFE
Taking Febinta-M Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding Febinta-M Tablet use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Febinta-M Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Febinta-M Tablet :
Should you forget a Febinta-M Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Febinta-M Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
